FibroBiologics logo

FibroBiologics

FBLG | NASDAQ
Chart Builder DCF Calculator
$0.90
-$0.03 (-2.92%)
At close: Nov 16, 2026, 4:00 PM ET
$0.90
$0.00 (+0.38%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.92%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
30.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #793/1021 (Top 78%)

Key Statistics

Market Data

Market Cap $6.02M
1D Range
0.89 0.95
52W Range
0.63 8.70

Valuation (TTM)

PE -0.15
PB 1.30
EV/EBITDA -0.23

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $180.00
Loading financial charts...

Profile

FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline include...

Sector Healthcare
Industry Biotechnology
Employees 15
IPO Date Feb 1, 2024
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
3
Consensus
Hold
Price Target
$180.00
Upside
+19900.00%
Buy (1)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.